tiprankstipranks
Nkarta (NKTX)
NASDAQ:NKTX
US Market
NKTX
Nkarta
RESEARCH TOOLSreports
Want to see NKTX full AI Analyst Report?

Nkarta (NKTX) Stock News & Sentiment

719 Followers
Nkarta (NKTX): Constructive Buy Rating on Leadership, Strategic Positioning, and Upcoming Value-Creating Milestones
Premium
Ratings
Nkarta (NKTX): Constructive Buy Rating on Leadership, Strategic Positioning, and Upcoming Value-Creating Milestones
18d ago
NKTX
Buy Rating Initiated on NKX019’s Differentiated CAR‑NK Platform and De‑Risked Autoimmune Opportunity Ahead of 2026 Proof‑of‑Concept Data
Premium
Ratings
Buy Rating Initiated on NKX019’s Differentiated CAR‑NK Platform and De‑Risked Autoimmune Opportunity Ahead of 2026 Proof‑of‑Concept Data
1M ago
NKTX
Nkarta Launches $100 Million At-the-Market Stock Offering
Premium
Company Announcements
Nkarta Launches $100 Million At-the-Market Stock Offering
1M ago
8K
NKTX
Is NKTX a Buy, Before Earnings?
Premium
Pre-Earnings
Is NKTX a Buy, Before Earnings?
2M ago
NKTX
Nkarta’s Strategic Management and Financial Strength Justify Buy Rating and $10 Target Price
Premium
Ratings
Nkarta’s Strategic Management and Financial Strength Justify Buy Rating and $10 Target Price
6M ago
NKTX
Nkarta Advances NKX019 Program Amid Financial Stability
Premium
Company Announcements
Nkarta Advances NKX019 Program Amid Financial Stability
6M ago
NKTX
Nkarta’s NKX019 Study: A Promising Step in Autoimmune Disease Treatment
Premium
Company Announcements
Nkarta’s NKX019 Study: A Promising Step in Autoimmune Disease Treatment
6M ago
NKTX
More NKTX News >

NKTX News on the Web

Nkarta (NKTX) Shares Surge 13% Following FDA Agreement on Outpatient Dosing
GuruFocus News
Bullish
Analysts Are Bullish on These Healthcare Stocks: Nkarta (NKTX), Harrow Health (HROW)
TipRanks News
Bullish
Nkarta (NKTX): Constructive Buy Rating on Leadership, Strategic Positioning, and Upcoming Value-Creating Milestones
TipRanks News
Bullish
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Biogen (BIIB) and Nkarta (NKTX)
TipRanks News
Bullish
Nkarta announces agreement with FDA on changes to Ntrust-1, Ntrust-2 trials
TipRanks News
Bullish
Nkarta price target lowered to $12 from $14 at Mizuho
TipRanks News
Neutral
Analysts Are Bullish on Top Healthcare Stocks: Nkarta (NKTX), BioCardia (BCDA)
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: BioCardia (BCDA) and Nkarta (NKTX)
TipRanks News
Bullish

News Score - Last 7 Days

Very Positive
NKTX
Sector Average
Media Buzz
This Week5 articles
Weekly Average2.75 articles
News Sentiment
This Week100%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is NKTX’s Media Buzz Sentiment?
5 articles about NKTX were published this week. In an average week, 2.75 articles are published.
    What is NKTX’s weekly average amount of articles?
    In an average week, 2.75 articles about NKTX are published.
      What is NKTX’s News Sentiment?
      100% of articles about NKTX were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        TVTXTravere Therapeutics
        HVOOpen Orphan Plc
        PBMPsyence Biomedical
        QDELQuidelOrtho
        Showing the stocks with the most bullish news sentiment over the past week